Influence of Efavirenz and Ritonavir on Human Brain P-Glycoprotein Activity Using PET Imaging
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Efavirenz (Primary) ; Ritonavir (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Pharmacodynamics; Pharmacogenomic
- 31 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Jan 2016 Planned primary completion date changed from 1 Jun 2014 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 22 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.